株式

株式会社Gaudi Clinical

Tokyo, JP · 3 known investors

gaudi-clinical.co.jp ↗

Gaudi Clinical develops KiOSK, a compact cell culture device that enables regenerative medicine procedures to be performed at clinical sites rather than centralized facilities. The company provides infrastructure and support for implementing regenerative medicine in healthcare institutions.

Investors · 3

JI

JIC Venture Growth InvestmentsTokyo

SA

Samurai IncubateTokyo

SH

Shizuoka Capital$790K – $241M